Biozen™ Portfolio • Aggregate Analysis (SEC) • Fragment/Sub-Unit Analysis (SEC & RP) • Native MS/Intact Mass (SEC & IEX & RP) • Oligonucleotide Characterization (RP) • Charge Variant Analysis (IEX) • Peptide Quantitation (RP) • Peptide Mapping (RP) • Average Drug Antibody Ratio (SEC & RP) • Glycan Mapping (HILIC) * Patented Titanium (BioTi™) infused biocompatible hardware * Inert separation media: First to Market and Unparalleled Inertness * Hydrophilic surface chemistry & pore control technology enable robust & reproducible aggregate analysis of mAbs, ADCs, and fusion proteins. * dSEC 2, Consistency in quantitation and identification * Reproducible performance for High Molecular weight species (HMWS), Monomer and Fragment * The Native SEC – HRMS, NIST antibody * dSEC 2, Aggregation & Fragment Separation Questions